57436-45-0 Usage
Uses
Used in Pharmaceutical Industry:
[(4-Methoxybenzoyl)thio]acetic acid is used as an intermediate compound for the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a valuable building block in the development of new drugs.
Used in Biochemical Research:
In the field of biochemical research, [(4-Methoxybenzoyl)thio]acetic acid is used as an enzyme inhibitor. Its ability to inhibit certain enzymes makes it a useful tool for studying enzyme function and developing targeted therapies.
Used in Anti-inflammatory and Analgesic Applications:
Due to its demonstrated anti-inflammatory and analgesic properties, [(4-Methoxybenzoyl)thio]acetic acid is used as a potential therapeutic agent for the treatment of pain and inflammation. Its effectiveness in these areas suggests that it could be a valuable component in the development of new medications for these conditions.
Used in Organic Synthesis:
In the field of organic synthesis, [(4-Methoxybenzoyl)thio]acetic acid is used as a versatile building block for the creation of a wide range of chemical compounds. Its unique structure and functional groups make it an attractive candidate for use in the synthesis of new molecules with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 57436-45-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,4,3 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 57436-45:
(7*5)+(6*7)+(5*4)+(4*3)+(3*6)+(2*4)+(1*5)=140
140 % 10 = 0
So 57436-45-0 is a valid CAS Registry Number.
57436-45-0Relevant academic research and scientific papers
Convergent stereoselective synthesis of multiple sulfated GlcNα(1,4)GlcAβ(1,4) dodecasaccharides
Tanaka, Hiroshi,Tateno, Yusuke,Takahashi, Takashi
supporting information, p. 9570 - 9582 (2013/01/16)
In this paper, we describe an effective method for the elongation of a GlcNα(1,4)GlcAβ(1,4) sequence using a GlcNTrocα(1,4)GlcA disaccharide unit and the synthesis of the N- and/or O-sulfated GlcNα(1,4)GlcAβ(1,4) oligosaccharides. N-Troc protection of Glc
